share_log

董事名單及其角色和職能

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

HKEX ·  Nov 18, 2024 20:56

Summary by Moomoo AI

華潤啤酒(控股)有限公司於2024年11月18日公布了最新的董事會成員名單及其在各個委員會中的職位。董事會成員包括執行董事侯孝海先生(主席)、趙春武先生(總裁)、趙偉先生(首席財務官),以及非執行董事Daniel Robinson先生、唐利清先生和郭巍女士。獨立非執行董事包括黃大寧先生、李家祥博士、賴顯榮先生、陳智思先生和蕭炯柱先生。公告中亦詳細列出了董事會成員在審核、薪酬、執行、財務及提名委員會中的角色,包括委員會主席(C)和委員會成員(M)的指定。
華潤啤酒(控股)有限公司於2024年11月18日公布了最新的董事會成員名單及其在各個委員會中的職位。董事會成員包括執行董事侯孝海先生(主席)、趙春武先生(總裁)、趙偉先生(首席財務官),以及非執行董事Daniel Robinson先生、唐利清先生和郭巍女士。獨立非執行董事包括黃大寧先生、李家祥博士、賴顯榮先生、陳智思先生和蕭炯柱先生。公告中亦詳細列出了董事會成員在審核、薪酬、執行、財務及提名委員會中的角色,包括委員會主席(C)和委員會成員(M)的指定。
China Res Beer (Holdings) Limited announced the latest list of board of directors and their positions in various committees on November 18, 2024. The board members include executive director Mr. Hou Xiaohai (Chairman), Mr. Zhao Chunwu (CEO), Mr. Zhao Wei (CFO), as well as non-executive directors Mr. Daniel Robinson, Mr. Tang Liqing, and Ms. Guo Wei. Independent non-executive directors include Mr. Huang Daning, Dr. Li Jiaxiang, Mr. Lai Xianrong, Mr. Chen Zhisi, and Mr. Xiao Jiongzhu. The announcement also details the roles of board members in the audit, remuneration, execution, finance, and nomination committees, including the designation of committee chair (C) and committee member (M).
China Res Beer (Holdings) Limited announced the latest list of board of directors and their positions in various committees on November 18, 2024. The board members include executive director Mr. Hou Xiaohai (Chairman), Mr. Zhao Chunwu (CEO), Mr. Zhao Wei (CFO), as well as non-executive directors Mr. Daniel Robinson, Mr. Tang Liqing, and Ms. Guo Wei. Independent non-executive directors include Mr. Huang Daning, Dr. Li Jiaxiang, Mr. Lai Xianrong, Mr. Chen Zhisi, and Mr. Xiao Jiongzhu. The announcement also details the roles of board members in the audit, remuneration, execution, finance, and nomination committees, including the designation of committee chair (C) and committee member (M).
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more